Impact on disease-free survival of the duration of ovarian function suppression, as postoperative adjuvant therapy, in premenopausal women with hormone receptor-positive breast cancer: a retrospective single-institution study

INTRODUCTION: Although tamoxifen (TAM) plus ovarian function suppression (OFS) is considered as a standard adjuvant treatment for premenopausal women with hormone receptor-positive breast cancer, the optimal duration of OFS has not yet been established. This retrospective study was designed to asses...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Breast Cancer
Main Authors: Ozaki, Yukinori, Tanabe, Yuko, Tamura, Nobuko, Ogura, Takuya, Kondoh, Chihiro, Miura, Yuji, Yoshimura, Kenichi, Kawabata, Hidetaka, Takano, Toshimi
פורמט: Artigo
שפה:Inglês
יצא לאור: Springer Japan 2018
נושאים:
Original Article
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC5906507/
https://ncbi.nlm.nih.gov/pubmed/29357022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12282-018-0836-x
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים